7.00 credits
59.0 h
Q1 and Q2
This learning unit is not open to incoming exchange students!
Teacher(s)
. SOMEBODY; Vanbever Rita;
Language
French
Prerequisites
Masters course in pharmaceutical sciences.
Main themes
• Concepts and production of protein and oligonucleotide biopharmaceuticals, 3h, VERMIJLEN David (ULB)
• Live biopharmaceuticals and vaccines
part A: concepts and biosecurity 6h, FONTAINE Véronique (ULB)
part B: risk management of cell and gene product release, 3h, MARINI Roland (ULiège)
• Formulation of biopharmaceuticals, 15h, VANBEVER Rita (UCLouvain)
• Quality control and analytical techniques for biopharmaceuticals, good practices and legal recommendations (8h):
part A: analytical methods, 5h, FILLET Mariane (ULiège)
part B: aspect of post-translational modifications, 3h, DELPORTE Cédric (ULB)
• From the laboratory to the dispensary: legal requirements (3h):
part A: patents and industrial protection, 5h, DI STEFANO Patrick (ULB)
part B: status and regulatory constraints for organic products, 3h, MALONNE Hugues (ULB)
part C: batch release procedure and legal framework for vaccines, 1h, TESOLIN Lorenzo (ULB)
part D: organization of quality assurance, 3h, PRONCE Thierry (UCLouvain)
part E: introduction to Biobanking, 3h, GOFFLOT Stéphanie (ULiège)
• Live biopharmaceuticals and vaccines
part A: concepts and biosecurity 6h, FONTAINE Véronique (ULB)
part B: risk management of cell and gene product release, 3h, MARINI Roland (ULiège)
• Formulation of biopharmaceuticals, 15h, VANBEVER Rita (UCLouvain)
• Quality control and analytical techniques for biopharmaceuticals, good practices and legal recommendations (8h):
part A: analytical methods, 5h, FILLET Mariane (ULiège)
part B: aspect of post-translational modifications, 3h, DELPORTE Cédric (ULB)
• From the laboratory to the dispensary: legal requirements (3h):
part A: patents and industrial protection, 5h, DI STEFANO Patrick (ULB)
part B: status and regulatory constraints for organic products, 3h, MALONNE Hugues (ULB)
part C: batch release procedure and legal framework for vaccines, 1h, TESOLIN Lorenzo (ULB)
part D: organization of quality assurance, 3h, PRONCE Thierry (UCLouvain)
part E: introduction to Biobanking, 3h, GOFFLOT Stéphanie (ULiège)
Learning outcomes
At the end of this learning unit, the student is able to : | |
At the end of this teaching unit, the student is able to: describe and explain the different aspects of specialties resulting from biotechnology. |
|
Content
The topics covered by the course module Biotechnologies include:
The courses are given at the three campus.
- Concepts and production of protein and oligonucleotide therapeutics
- Living biotherapeutics, vaccines and biosecurity
- Formulation of biopharmaceuticals
- Quality control and analytical techniques for biologicals
- From the bench to the pharmacist: legal requirements
The courses are given at the three campus.
Teaching methods
Ex cathedra course (Powerpoint presentations). A copy of these documents is available to students.
In some topics: flipped classrooms, formative assessments.
In some topics: flipped classrooms, formative assessments.
Evaluation methods
Integrated oral assessment in front of a jury of module teachers.
Teaching materials
- Copie des diapositives
Faculty or entity
FARM
Programmes / formations proposant cette unité d'enseignement (UE)
Title of the programme
Sigle
Credits
Prerequisites
Learning outcomes
Advanced Master in Industrial Pharmacy